Simply Wall St.
Institutional investors in Monopar Therapeutics Inc. (NASDAQ:MNPR) see US$66m decrease in market cap last week, although long-term gains have benefitted them.
➖
AI Sentiment
Neutral
4/10
Monopar Therapeutics Inc. News
Latest updates and market news for MNPR
2 news
Feb 8 - Feb 14, 2026
Page 1
Investor's Business Daily
Broadcom Stock Sees Improved Relative Strength Rating
📊
AI Sentiment
Positive
7/10
Share this news page